Related references
Note: Only part of the references are listed.Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
Alessandro Favilli et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)
Theaflavin-3-gallate, a natural antagonist for Hsp90: In-silico and in-vitro approach
Kinjal Bhadresha et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India
Urvashi B. Singh et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
Sarah Huff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients
Zeinab Mohseni Afshar et al.
REVIEWS IN MEDICAL VIROLOGY (2022)
COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety
Katherine Kricorian et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Natural-like products as potential SARS-CoV-2 Mproinhibitors:in-silicodrug discovery
Mahmoud A. A. Ibrahim et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation
Pallab Kar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
Vijay Kumar Bhardwaj et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Theaflavin Chemistry and Its Health Benefits
Zhiguo Shan et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors
Mahmoud A. A. Ibrahim et al.
MOLECULES (2021)
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2
Jatin Sharma et al.
FOOD CHEMISTRY (2021)
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India
J. Beena Philomina et al.
JOURNAL OF INFECTION (2021)
Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study
Mahmoud A. A. Ibrahim et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2021)
Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice
Tarlan Mamedov et al.
VIRUSES-BASEL (2021)
Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor
Jinbiao Liu et al.
CELL AND BIOSCIENCE (2021)
Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2
Vijay Kumar Bhardwaj et al.
FRONTIERS IN MEDICINE (2021)
SARS-CoV-2 re-infection: development of an epidemiological definition from India
Aparna Mukherjee et al.
EPIDEMIOLOGY AND INFECTION (2021)
Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective
Rahul Singh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Forty years with coronaviruses
Susan R. Weiss
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase
Vijay Kumar Bhardwaj et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2020)
Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro
Minsu Jang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Mohammad M. Ghahremanpour et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Theaflavins inhibit glucose transport across Caco-2 cells through the downregulation of the Ca2+/AMP-activated protein kinase-mediated glucose transporter SGLT1
Baorui Li et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors
Mahmoud A. A. Ibrahim et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2020)
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
Zhixing Zhu et al.
RESPIRATORY RESEARCH (2020)
Lessons learned about steered molecular dynamics simulations and free energy calculations
Fernando Martin Boubeta et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
Calculating protein-ligand binding affinities with MMPBSA: Method and error analysis
Changhao Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2016)
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
Kesava Rao V. Kurapati et al.
FRONTIERS IN MICROBIOLOGY (2016)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Coronaviruses: Important Emerging Human Pathogens
Christopher M. Coleman et al.
JOURNAL OF VIROLOGY (2014)
Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations
Wenbo Yu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)
Natural products as starting points for future anti-malarial therapies: going back to our roots?
Timothy N. C. Wells
MALARIA JOURNAL (2011)
Antioxidative and anti-carcinogenic activities of tea polyphenols
Chung S. Yang et al.
ARCHIVES OF TOXICOLOGY (2009)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
HMDB: the human metabolome database
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2007)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro
M Nakai et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Antiviral flavonoids from the root bark of Morus alba L.
J Du et al.
PHYTOCHEMISTRY (2003)